Enovis Announces Fourth Quarter and Full Year 2024 Results
Provided By GlobeNewswire
Last update: Feb 26, 2025
Wilmington, DE, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the fourth quarter and full year ended December 31, 2024. The Company will host an investor conference call and live webcast to discuss these results today at 8:30 am ET.
Read more at globenewswire.com
